BDNF and breast cancer: Previously, we have shown that elevated levels of pro-inflammatory cytokines IL-1β and IL-6 corresponded with poorer cognitive response and higher BDNF levels were protective against persistent CRCI in a cohort of early stage breast cancer (ESBC) patients [10,56].